Financials
Income statement
Fiscal date | Apr 2025 | Jan 2025 | Oct 2024 | Jul 2024 |
---|---|---|---|---|
Total reported revenue | 9.8B | 10.0B | 9.4B | 9.3B |
Cost of revenue | 4.5B | 4.4B | 4.2B | 4.3B |
Gross profit | 7.6B | 7.8B | 7.3B | 7.2B |
Operating expense | ||||
Research & development | 1.5B | 1.4B | 1.4B | 1.3B |
Selling general and admin | 4.1B | 4.2B | 4.0B | 3.9B |
Other operating expenses | — | — | — | — |
Operating income | 2.0B | 2.1B | 1.9B | 1.9B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | — | — | — | — |
Other income expense | -4M | -130M | -203M | -45M |
Pretax income | 2.0B | 2.0B | 1.7B | 1.8B |
Tax provision | 433M | 280M | 219M | 408M |
Net income | 1.5B | 1.7B | 1.5B | 1.4B |
Basic EPS | 1.6 | — | 1.6 | 1.5 |
Diluted EPS | 1.6 | — | 1.6 | 1.5 |
Basic average shares | 960M | — | 956M | 964M |
Diluted average shares | 970M | — | 965M | 973M |
EBITDA | 2.9B | 3.2B | 3.0B | 2.9B |
Net income from continuing op. | 1.5B | 1.7B | 1.5B | 1.4B |
Minority interests | — | — | — | — |
Preferred stock dividends | — | — | — | — |